Sero-Prevalence of Hepatitis C virus Antibody Among Screened Populations and Certain Risk groups in Al-Anbar Governorate, West of Iraq
Al- Anbar Medical Journal,
2017, Volume 14, Issue 1, Pages 33-39
AbstractGlobally an estimated 130–170 million persons (2%–3% of the world’s population) are living with hepatitis C virus (HCV) infection. This infection, particularly in its chronic form, is associated with sizable morbidity and mortality. More than 350 000 deaths are attributed to HCV infection each year, most of which are caused by liver cirrhosis and hepatocellular carcinoma (HCC).
Objective: - This study aims to determine the prevalence of anti HCV antibody in AL-Anbar governorate among screened groups.
Patients and Methods: - This is a retrospective study conducted and achieved in Al-Anbar Central Laboratory during the period from January to Dec 2012. Requestionary sheet included age and sex. The sera from study group
Individuals were submitted for screening by preliminary screening test, dipstick immunoassay which depends on immuno-chromatography for detection of anti HCV antibody. After that all Anti-HCV antibody positive sera were examined for the presence of anti HCV antibody by enzyme linked immunosorbent assay (ELISA) for 1-blood donor's. 2-Rotein screened populations [contacts, pre-marriage, before surgery, before Endoscopic and dental procedures and among 3- certain risk groups [pregnant women, midwives and health worker].
Result: - Our study revealed the prevalence of anti HCV antibody was 0.16% among blood donors. 0.00% among health workers and midwives. (0.05%) among contacts. (0.07%), among participants with non-urgent operation. (0.10%) among pregnant women and with 3.53% among Routine screened population.
Conclusion: - The prevalence of hepatitis C virus antibody is high among routine screened population and low among certain high risk groups. Although there is discrepancy between these two groups HCV screening is highly recommended.
- Article View: 31
- PDF Download: 5